Dow Down 0.18% Nasdaq Up 0.39%

Clovis Oncology, Inc. (CLVS)

-NasdaqGS
48.30 0.74(1.56%) Sep 2, 3:59PM EDT
|After Hours : 47.50 Down 0.80 (1.66%) Sep 2, 7:04PM EDT
Prev Close:47.56
Open:48.09
Bid:46.00 x 100
Ask:49.19 x 1100
1y Target Est:81.11
Beta:2.19
Earnings Date:Oct 29 - Nov 3 (Est.)
Day's Range:47.52 - 49.53
52wk Range:35.33 - 93.33
Volume:647,906
Avg Vol (3m):810,489
Market Cap:1.64B
P/E (ttm):N/A
EPS (ttm):-3.25
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for CLVS

Comparison

Symbol% ChgMkt Cap
CLVSUp 1.56%1.64B
IMMU306.35M
LRUSF57.96M
THLD243.40M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):118.55
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-4.06
Quarterly EPS Est (Sep-14) :-1.07
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback